Jacob Kagan

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Mitochondria as a target for early detection and diagnosis of cancer
    Jacob Kagan
    Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland 20852, USA
    Crit Rev Clin Lab Sci 42:453-72. 2005
  2. ncbi request reprint Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools
    Jacob Kagan
    Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA
    Cancer Res 67:4545-9. 2007
  3. pmc Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
    John T Wei
    John T Wei, University of Michigan, Ann Arbor, MI Ziding Feng, Elissa Brown, Aron Y Joon, Jackie Dahlgren, Fred Hutchinson Cancer Research Center Daniel W Lin, University of Washington, Seattle, WA Alan W Partin, Lori Sokoll, Daniel W Chan, Johns Hopkins University, Baltimore Jacob Kagan, Sudhir Srivastava, National Cancer Institute, Bethesda, MD Ian Thompson, The University of Texas San Antonio, San Antonio Yair Lotan, The University of Texas Southwestern Medical Center, Dallas, TX Adam S Kibel, Harvard University, Cambridge Martin G Sanda, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA J Erik Busby, University of South Carolina, Greenville, SC Mohamed Bidair, San Diego Clinical Trials, San Diego, CA Samir S Taneja, New York University, New York, NY and Rosalia Viterbo, Fox Chase Cancer Center, Philadelphia, PA
    J Clin Oncol 32:4066-72. 2014
  4. pmc [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study
    Lori J Sokoll
    Departments of Pathology and Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 180:539-43; discussion 543. 2008
  5. ncbi request reprint Proteomic analysis of cancer-cell mitochondria
    Mukesh Verma
    Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA
    Nat Rev Cancer 3:789-95. 2003
  6. doi request reprint ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity
    Anshu Rastogi
    1 Center For Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    Monoclon Antib Immunodiagn Immunother 33:201-8. 2014
  7. ncbi request reprint Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio
    Howard L Parnes
    Prostate and Urologic Cancer Researh Group, Division of Cancer Prevention, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA
    J Urol 171:S68-74; discussion S75. 2004
  8. ncbi request reprint Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility
    O John Semmes
    Department of Microbiology and Molecular Cell Biology, Virginia Prostate Center, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    Clin Chem 51:102-12. 2005
  9. ncbi request reprint The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology
    William E Grizzle
    University of Alabama at Birmingham, Birmingham, AL, USA
    Urol Oncol 22:337-43. 2004
  10. pmc Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias
    Dale McLerran
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Clin Chem 54:44-52. 2008

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Mitochondria as a target for early detection and diagnosis of cancer
    Jacob Kagan
    Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland 20852, USA
    Crit Rev Clin Lab Sci 42:453-72. 2005
    ....
  2. ncbi request reprint Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools
    Jacob Kagan
    Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA
    Cancer Res 67:4545-9. 2007
    ....
  3. pmc Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
    John T Wei
    John T Wei, University of Michigan, Ann Arbor, MI Ziding Feng, Elissa Brown, Aron Y Joon, Jackie Dahlgren, Fred Hutchinson Cancer Research Center Daniel W Lin, University of Washington, Seattle, WA Alan W Partin, Lori Sokoll, Daniel W Chan, Johns Hopkins University, Baltimore Jacob Kagan, Sudhir Srivastava, National Cancer Institute, Bethesda, MD Ian Thompson, The University of Texas San Antonio, San Antonio Yair Lotan, The University of Texas Southwestern Medical Center, Dallas, TX Adam S Kibel, Harvard University, Cambridge Martin G Sanda, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA J Erik Busby, University of South Carolina, Greenville, SC Mohamed Bidair, San Diego Clinical Trials, San Diego, CA Samir S Taneja, New York University, New York, NY and Rosalia Viterbo, Fox Chase Cancer Center, Philadelphia, PA
    J Clin Oncol 32:4066-72. 2014
    ....
  4. pmc [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study
    Lori J Sokoll
    Departments of Pathology and Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 180:539-43; discussion 543. 2008
    ..This study evaluated the [-2]proenzyme prostate specific antigen serum marker using a blinded reference specimen set from 3 National Cancer Institute Early Detection Research Network centers from men with an indication for prostate biopsy...
  5. ncbi request reprint Proteomic analysis of cancer-cell mitochondria
    Mukesh Verma
    Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA
    Nat Rev Cancer 3:789-95. 2003
    ....
  6. doi request reprint ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity
    Anshu Rastogi
    1 Center For Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    Monoclon Antib Immunodiagn Immunother 33:201-8. 2014
    ....
  7. ncbi request reprint Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio
    Howard L Parnes
    Prostate and Urologic Cancer Researh Group, Division of Cancer Prevention, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA
    J Urol 171:S68-74; discussion S75. 2004
    ..We describe the current National Cancer Institute chemoprevention agent development program and provide a summary of the intermediate end points used...
  8. ncbi request reprint Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility
    O John Semmes
    Department of Microbiology and Molecular Cell Biology, Virginia Prostate Center, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    Clin Chem 51:102-12. 2005
    ..This report describes the first stage of a National Cancer Institute/Early Detection Research Network-sponsored multiinstitutional evaluation and validation of this approach for detection of prostate cancer...
  9. ncbi request reprint The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology
    William E Grizzle
    University of Alabama at Birmingham, Birmingham, AL, USA
    Urol Oncol 22:337-43. 2004
    ..The methodologies used for this evaluation will prove useful for guiding future biomarker studies in this challenging disease...
  10. pmc Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias
    Dale McLerran
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Clin Chem 54:44-52. 2008
    ..Details of this 3-stage process have been described. This report describes the development of the algorithm and results of the blinded test for stage 1...
  11. pmc SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer
    Dale McLerran
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Clin Chem 54:53-60. 2008
    ..This report is the 2nd of 2 companion articles describing a validation study of a SELDI-TOF MS approach with IMAC surface sample processing to identify prostatic adenocarcinoma...